Venetoclax for Children and Adolescents with Acute Lymphoblastic Leukemia and Lymphoblastic LymphomaAmber Gibson, Branko Cuglievan, César Núnêz et al.|Cancers|2021Cited by 66
Blastic plasmacytoid dendritic cell neoplasm: a comprehensive review in pediatrics, adolescents, and young adults (AYA) and an update of novel therapiesBranko Cuglievan, Naveen Pemmaraju, Jeremy Connors et al.|Leukemia|2023Cited by 52
Early Results of the Phase I/II Study Investigating the All-Oral Combination of the Menin Inhibitor Revumenib (SNDX-5613) with Decitabine/Cedazuridine (ASTX727) and Venetoclax in Acute Myeloid Leukemia (SAVE)Ghayas C. Issa, Hagop M. Kantarjian, Branko Cuglievan et al.|Blood|2023Cited by 46
<i>ATM</i> germ line pathogenic variants affect outcomes in children with ataxia-telangiectasia and hematological malignanciesSarah Elitzur, Kjeld Schmiegelow, Ruth Shiloh et al.|Blood|2024Cited by 24